163 related articles for article (PubMed ID: 23975361)
1. Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).
Rocha LF; Marangoni RG; Sampaio-Barros PD; Levy-Neto M; Yoshinari NH; Bonfa E; Steen V; Kowalski SC
Clin Rheumatol; 2014 May; 33(5):699-706. PubMed ID: 23975361
[TBL] [Abstract][Full Text] [Related]
2. Validation of Turkish version of the Scleroderma Health Assessment Questionnaire.
Temiz Karadag D; Karakas F; Tekeoglu S; Yazici A; Isik OO; Cefle A
Clin Rheumatol; 2019 Jul; 38(7):1917-1923. PubMed ID: 30840212
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire.
Genrinho I; Ferreira PL; Santiago T; Carones A; Mazeda C; Barcelos A; Beirão T; Costa F; Santos I; Couto M; Rato M; Terroso G; Monteiro P
Int J Environ Res Public Health; 2023 Nov; 20(22):. PubMed ID: 37998293
[TBL] [Abstract][Full Text] [Related]
4. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
[TBL] [Abstract][Full Text] [Related]
5. Translation and validation of the Persian version of the scleroderma health assessment questionnaire (SHAQ).
Nayebirad S; Emamzade A; Sedaghat M; Montazeri A; Gharibdoost F; Yaseri M; Tamartash Z; Salehi S; Kiani T; Soltani S; Mohammadzadegan A; Eshaghi A; Madanipour MR; Atef Yekta R; Kavosi H
Intern Emerg Med; 2023 Apr; 18(3):811-819. PubMed ID: 36854998
[TBL] [Abstract][Full Text] [Related]
6. Translation and cross-cultural adaptation of the Scleroderma Health Assessment Questionnaire to Brazilian Portuguese.
Orlandi AC; Cardoso FP; Santos LM; Cruz Vda G; Jones A; Kyser C; Natour J
Sao Paulo Med J; 2014; 132(3):163-9. PubMed ID: 24788030
[TBL] [Abstract][Full Text] [Related]
7. Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis.
Ng X; Thumboo J; Low AH
Int J Rheum Dis; 2012 Jun; 15(3):268-76. PubMed ID: 22709488
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.
Hesselstrand R; Nilsson JÅ; Sandqvist G
Scand J Rheumatol; 2013; 42(4):317-24. PubMed ID: 23442162
[TBL] [Abstract][Full Text] [Related]
9. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).
Georges C; Chassany O; Mouthon L; Tiev K; Toledano C; Meyer O; Marjanovic Z; Heneggar C; Papo T; Crickx B; Sereni D; Cabane J; Farge D
Clin Rheumatol; 2005 Feb; 24(1):3-10. PubMed ID: 15674652
[TBL] [Abstract][Full Text] [Related]
10. The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties.
Johnson SR; Hawker GA; Davis AM
Arthritis Rheum; 2005 Apr; 53(2):256-62. PubMed ID: 15818719
[TBL] [Abstract][Full Text] [Related]
11. Systemic Sclerosis Quality of Life Questionnaire (SScQoL): translation into Turkish and assessing its psychometric properties.
Sarac DC; Bayraktar D; Tore NG; Kurut Aysin I; Otman E; Inanc I; Demirbas S; Coskun B; Erol K; Ustun O; Akatay EA; Oskay D; Gucenmez S; Ozmen M; Akar S
Clin Rheumatol; 2023 Aug; 42(8):2135-2143. PubMed ID: 37178266
[TBL] [Abstract][Full Text] [Related]
12. Validation of Turkish version of the Cochin 17-item Scleroderma Functional scale.
Tore NG; Oskay D; Avanoglu Guler A; Tufan A
Physiother Theory Pract; 2023 Mar; 39(3):576-581. PubMed ID: 34978265
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Swedish version of PROMIS-29v2 and FACIT-Dyspnea Index in patients with systemic sclerosis.
Wuttge DM; Chaplin JE; Sandqvist G
Disabil Rehabil; 2023 Jul; 45(15):2517-2525. PubMed ID: 36129325
[TBL] [Abstract][Full Text] [Related]
14. Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch.
Meijs J; Pors D; Vliet Vlieland TP; Huizinga TW; Schouffoer AA
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-41-8. PubMed ID: 24984228
[TBL] [Abstract][Full Text] [Related]
15. Cross-cultural adaptation of the disabilities of the arm, shoulder, and hand (DASH) questionnaire into Hungarian and investigation of its validity in patients with systemic sclerosis.
Varjú C; Bálint Z; Solyom AI; Farkas H; Kárpáti E; Berta B; Kumánovics G; Czirják L; Nagy Z
Clin Exp Rheumatol; 2008; 26(5):776-83. PubMed ID: 19032808
[TBL] [Abstract][Full Text] [Related]
16. Translation, validation and cross-cultural adaptation of the mouth handicap in systemic sclerosis questionnaire into the Turkish language.
Tore NG; Sarì F; Tunà Z; Kucuk H; Haznedaroglu S; Oskay D
Int J Rheum Dis; 2020 May; 23(5):669-673. PubMed ID: 32100463
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients.
Suliman YA; Kafaja S; Alemam M; Shaweesh Y; Tavakoli K; Furst DE
J Scleroderma Relat Disord; 2021 Oct; 6(3):236-241. PubMed ID: 35387210
[TBL] [Abstract][Full Text] [Related]
18. The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis.
Ziemek J; Man A; Hinchcliff M; Varga J; Simms RW; Lafyatis R
Rheumatology (Oxford); 2016 May; 55(5):911-7. PubMed ID: 26880832
[TBL] [Abstract][Full Text] [Related]
19. Crosscultural Adaptation and Validation of the Korean Version of the New Knee Society Knee Scoring System.
Kim SJ; Basur MS; Park CK; Chong S; Kang YG; Kim MJ; Jeong JS; Kim TK
Clin Orthop Relat Res; 2017 Jun; 475(6):1629-1639. PubMed ID: 28265885
[TBL] [Abstract][Full Text] [Related]
20. Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis.
Gualtierotti R; Ingegnoli F; Scalone L; Cortesi P; Bruschi E; Gerosa M; Meroni PL
Swiss Med Wkly; 2016; 146():w14394. PubMed ID: 28102877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
